Select Page

We speak science. It’s in our DNA.

With our biomedical research backgrounds and biotech communications experience, we translate the science and technology into the value story that matters for your stakeholders and business goals.

Jessica Yingling, Ph.D.

President and Founder

Jessica founded Little Dog Communications Inc. to work with companies and organizations that, through research, innovation and new technologies are helping develop tomorrow’s medicines and re-imagining the future of healthcare.

The DNA of communications is both science and art.
“It’s more than a website, a PowerPoint or a press release, it’s your story.  It needs to inspire others, so together you can achieve something important.”

– Jessica Yingling, Ph.D., President of Little Dog Communications

Biotech and healthcare communications have an added layer of complexity due to the science. Jessica merges a biomedical research background with communications EQ to find the best way to convey new science and technologies to motivate audiences and stakeholders.

Before founding Little Dog Communications in 2011, Jessica was director of corporate communications at Fate Therapeutics, where she built and successfully executed a complete corporate communications program that established Fate as a pioneering company in stem cell medicines. This program led to numerous company awards and recognitions, including being named one of the most innovative biotechs by Fast Company.

Previous to Fate, Jessica was at Porter Novelli Life Sciences, where she gained experience working with a wide range of accounts from start-up biotechs translating early stage technology to public life sciences companies with marketed products.

Jessica achieved her Ph.D. in biomedical sciences from University of California, San Diego, where she was awarded a National Science Foundation pre-doctoral fellowship. She is author in multiple top-tier review articles and research papers, including Cell. She earned a B.S. with honors in biochemistry and art history from the University of Arizona, where she received a number of academic and research scholarships and awards.


Christine (Chris) Castro has more than 25 years of experience leading corporate communications and public relations functions for publicly held global brands in the media, technology, and health science sectors. She currently serves as an advisor and consultant for an array of startups and privately held companies in the technology and biotech sectors. Prior this, Chris has held the following roles: Chief of Staff at Elysium Health; Senior Vice President, Communications at CBS Corporation; Vice President, Communications at 23andMe; Senior Vice President, Corporate Relations at Genentech; Chief Communications Officer at Yahoo; Vice President, Corporate Communications at The Walt Disney Company; and Director, Corporate Communications at American International Group. Chris earned her B.A. in journalism and her M.A. in communications management from the University of Southern California. 

Elissa Woods is a graphic designer who specializes in multi-media content creation for small biotech companies. In 2020, Elissa was awestruck by the innovation of Operation Warp Speed and has been committed to shaping biotech communications through the power of social media and design ever since. At Little Dog, she supports our clients with graphic design, social media strategy and content, and project management. She graduated top of her class having completed her master’s program in one year instead of three and has won an award for copywriting. Elissa holds a master’s degree in Media Design from Full Sail University.
What started from the joy of placing a client in the Associated Press over 13 years ago, has transformed into a career of storytelling for high profile brands and local companies alike.  Kelly Kass is a passionate and trusted public relations expert who takes a strategic approach in counseling clients on all facets of media relations including media training, story mining, pitch strategy, and media communication. Previously, as vice president at Weber Shandwick where she spent a decade of her career, Kelly was called on throughout the company as the media specialist who could always navigate the complex media landscape, often because of her exceptional media relationships at top tier media outlets. For Little Dog Communications, Kelly led the media strategy on the FDA approval of the first blood test to aid in the evaluation of traumatic brain injury developed by Banyan Biomarkers and secured coverage in the ABC News, Associated Press, CNBC, and CNN. Kelly consistently secures national placements for clients including: ABC World News, The Today Show, Nightline, CNN, CNN Money, Forbes and The New York Times. Past and current clients include: Sutter Health, Mount Auburn Hospital, Nike, Burt's Bees, Ocean Spray, Del Monte, General Motors, and Verizon. Kelly has also been published as the author of “Securing Coverage Takes Smart Storytelling and Careful Follow up,” in the PR News Media Relations Guide Book. Kelly holds a Bachelor of Arts in public relations and a minor in fine arts from Quinnipiac University.  After many cold Boston winters, Kelly now enjoys living in San Diego.

Pin It on Pinterest